Reproducibility of Fuhrman nuclear grade: Advantages of a two-grade system;Reproductibilité du grade nucléaire de Fuhrman: Avantages d'un regroupement en deux grades

Progres en Urologie

Volumn 16, Issue 3, 2006, Pages 281-285

  Letourneux, Hervé ^a   Lindner, Véronique ^b   Lang, Hervé ^a   Massfelder, Thierry ^c   Meyer, Nicolas ^b   Saussine, Christian ^a   Jacqmin, Didier ^a  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Fuhrman grade; Pathology; Prognostic factor; Renal cell carcinoma

Indexed keywords

HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; PATHOLOGY; REPRODUCIBILITY; REVIEW; UROLOGIC EXAMINATION;

CARCINOMA, RENAL CELL; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; KIDNEY NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 33748040089     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. MEJEAN A., OUDARD S., THIOUNN N.: Prognostic factors of renal cell carcinoma. J. Urol., 2003; 169: 821-827.
2. KONTAK J.A., CAMPBELL S.C.: Prognostic factors in renal cell carcinoma. Urol. Clin. North. Am., 2003; 30: 467-480.
3. MEDEIROS L.J.: Grading of Renal Cell Carcinoma. Cancer, 1997; 80: 990-991.
4. FUHRMAN S.A., LASKY L.C., LIMAS C.: Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol., 1982; 6: 655-663.
5. MEJEAN A., ANDRE M., DOUBLET J.D., FENLDER J. P., DE FROMONT M., HELENON O., LANG H., NEGRIER S., PATARD J.J., PIECHAUD T.: Comité de Cancérologie de l'Association Française d'Urologie. Tumeur du rein. Recommandations 2004 en Onco-Urologie. Prog. Urol., 2004; 14: 997-1035.
6. MICKISCH G., CARBALLIDO J., HELLSTEN S., SCHULZE H., MENSINK H.: European Association of Urology. Guidelines on renal cell cancer. Eur. Urol. 2001; 40: 252-255.
7. ARNER O., BLANCK C., VON SCHREEB T.: Renal adenocarcinoma: morphology, grading of malignancy, prognosis. Acta. Chir. Scand., 1965; 346: 1-51.
8. SKINNER D.G., COLVIN R.B., VERMILLION C.D., PFISTER R.C., LEADBETTER W.F.: Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer, 1971; 28: 1165-1177.
9. SYRJÄNEN K., HJELT L.: Grading of human renal adenocarcinoma. Scand. J. Urol. Nephrol., 1978; 12: 49-55.
10. BRETHEAU D., LECHEVALLIER E., DE FROMONT M., SAULT M.C., RAMPAL M., COULANGE C.: Prognostic value of nuclear grade of renal cell carcinoma. Cancer, 1995; 76: 2543-2549.
11. CHEVILLE J.C., BLUTE M.L., ZINCKE H., LOHSE C.M., WEAVER A.L.: Stage pT1 conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival. J. Urol., 2001; 166: 453-456.
12. DI SILVERIO F., CASALE P., COLELLA D., ANDREA L., SECCARECCIA F., SCIARRA A.: Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma. Cancer, 2000; 88: 835-843.
13. DUPRE F., GUYETANT S., CHAUTARD D., BURTIN P., SAINT-ANDRE J.P.: Prognostic value of Furhman's grade in renal cell carcinoma. A study of 170 cases. Ann. Pathol., 1998; 18: 88-97.
14. FICARRA V., MARTIGNONI G., MAFFEI N., BRUNELLI M., NOVARA G., ZANOLLA L., PEA M., ARTIBANI W.: Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer, 2005; 103: 68-75.
15. GELB A.B., SHIBUYA R.B., WEISS L.M., MEDEIROS L.J.: Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am. J. Surg. Pathol., 1993; 17: 275-286.
16. GIBERTI C., ONETO F., MARTORANA G., ROVIDA S., CARMIGNANI G.: Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur. Urol., 1997; 31: 40-48.
17. GIMBERGUES P., GUY L., COSTES-CHARLET N., KWIATOWSKY F., KEMENY J.L., BOITEUX J.P.: Value of Fuhrman's nuclear grade: comparison with other prognostic factors of renal epithelial tumors. Prog. Urol., 1999; 9: 1039-1045.
18. GREEN L.K., AYALA A.G., RO J.Y., SWANSON D.A., GRIGNON D.J., GIACCO G.G., GUINEE V.F.: Role of nuclear grading in stage I renal cell carcinoma. Urology, 1989; 34: 310-315.
19. GRIGNON D.J., AYALA A.G., EL-NAGGAR A., WISHNOW K.I., RO J.Y., SWANSON D.A., MCLEMORE D., GIACCO G.G., GUINEE V.F.: Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Cancer, 1989; 64: 2133-2140.
20. MEDEIROS L.J., GELB A.B., WEISS L.M.: Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer, 1988; 61: 1639-1651.
21. MINERVINI A., LILAS L., MINERVINI R., SELLI C.: Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients. Cancer, 2002; 94: 2590-2595.
22. MUNICHOR M., LICHTIG C., TZIN G., WEISS A.: Prognostic significance of granular cell content in renal cell carcinoma. Eur. Urol., 1992; 22: 204-208.
23. PATARD J.J., BENSALAH K., VINCENDEAU S., RIOUX-LECLERQ N., GUILLE F., LOBEL B.: Correlation between the mode of presentation of renal tumors and patient survival. Prog. Urol., 2003; 13: 23-28.
24. TSUI K.H., SHVARTS O., SMITH R.B., FIGLIN R.A., DEKERNION J.B., BELLDEGRUN A.: Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol., 2000; 163: 1090-1095.
25. AL-AYNATI M., CHEN V., SALAMA S., SHUHAIBAR H., TRELEAVEN D., VINCIC L.: Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch. Pathol. Lab. Med., 2003; 127: 593-596.
26. LANG H., LINDNER V., DE FROMONT M., MOLINIE V., LETOURNEUX H., MEYER N., MARTIN M., JACQMIN D.: Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up. Cancer, 2005; 103: 625-629.
27. LANIGAN D., CONROY R., BARRY-WALSH C., LOFTUS B., ROYSTON D., LEADER M.: A comparative analysis of grading systems in renal adenocarcinoma. Histopathology, 1994; 24: 473-476.
28. BARRIOL D., LECHEVALLIER E., ANDRE M., DANIEL L., ORTEGA J.C., ROSSI D., COULANGE C.: Les biopsies percutanées à l'aiguille fine des tumeurs solides du rein sous guidage tomodensitométrique. Prog. Urol. 2000; 10: 1145-1151.
29. NEUZILLET Y., LECHEVALLIER E., ANDRE M., DANIEL L., COULANGE C.: Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J. Urol., 2004; 171: 1802-1805.
30. JAFF A., MOLINIE V., MELLOT F., GUTH A., LEBRET T., SCHERRER A. Evaluation of imaging-guided fine-needle percutaneous biopsy of renal masses. Eur Radiol., 2005; 15: 1721-1726.
31. LECHEVALLIER E., ANDRE M., BARRIOL D., DANIEL L., EGHAZARIAN C., DE FROMONT M., ROSSI D., COULANGE C.: Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology, 2000; 216: 506-510.
32. WUNDERLISCH H., HINDERMANN W., AL MUSTAFA A.M., REICHELT O., JUNKER K., SCHUBERT J.: The accuracy of 250 fine needle biopsies of renal tumors. J Urol., 2005; 174: 44-46.
33. GOLDSTEIN N.S.: Grading of renal cell carcinoma. Urol. Clin. North. Am., 1999; 26: 637-642.
34. GOLDSTEIN N.S.: The current state of renal cell carcinoma grading. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 1997; 80: 977-980.
35. LOHSE C.M., BLUTE M.L., ZINCKE H., WEAVER A.L., CHEVILLE J.C.: Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am. J. Clin. Pathol., 2002; 118: 877-886
36. JACQMIN D.: Traitement adjuvant: Perspectives. Communication à ARTUR, 30 septembre 2005, Chantilly.